We report the 1lth human case of bloodstream infection with Plesiomonas shigelloides. This was the first case without any apparent underlying immunocompromising disease, and the patient was the first adult to survive the infection. We review all the extraintestinal cases associated with this organism, giving special attention to the clinical characteristics of the bloodstream infections reported previously.
A physical examination of the patient at the time of admission revealed a blood pressure of 115/75 mm Hg and a pulse rate of 88 beats per min in a supine position, changing to 95/60 mm Hg and 100 beats per min in a sitting position. His oral temperature was 40°C. His skin was normal, and his heart sounds were normal without murmurs, rubs, or gallops. He had mild tenderness on palpation of the left lower abdominal quadrant and normal bowel sounds. The rectal exam revealed tenderness, and the stool guaiac test was negative.
The complete blood count showed a leukocyte count of 4,300/mm3 with 47% segmented polymorphonuclear cells and 39% band forms, a hematocrit of 45.4%, and a platelet count of 166,000/mm3. A Wright stain of the stool did not reveal leukocytes.
Overnight intravenous hydration was begun after cultures of blood and stool were obtained. On hospital day 2, the left ankle of the patient was tender and swollen. Arthrocentesis yielded fluid containing 131,000 erythrocytes per mm3 and 266,000 leukocytes per mm3 (100% polymorphonuclear cells) and a glucose level of 5 mg/dl. A Gram stain of the joint fluid revealed gram-negative bacteria within leukocytes and urate crystals. Intravenous ampicillin (1 g every 6 h) and tobramycin (80 mg every 4 h) were begun on hospital day 2. Intravenous chloramphenicol (1 g every 6 h) was added because of a persistent fever of up to 40°C. P. shigelloides was isolated from blood, stool, and joint fluid cultures. After antibiotic susceptibilities became known, intravenous cefazolin (1 g every 6 h) was started, and ampicillin and tobramycin were discontinued. Chloramphenicol was discontinued on hospital day 8, and the cefazolin was increased to a dosage of 3 g every 6 h. In addition to antibiotic therapy, the left ankle of the patient required daily arthrocentesis for 2 days, followed by open drainage on hospital day 4. Subsequently, plain radiographs revealed cortical erosion in the ankle joint, consistent with osteomyelitis. Cefazolin was discontinued on hospital day 18, and intravenous ceftriaxone (2 g every 24 h) was begun and continued for 28 days. Ceftriaxone was then discontinued, and oral cephalexin (500 mg every 6 h) was administered for 14 days. The patient improved steadily during therapy and was still asymptomatic 7 months after completing therapy.
Bacteriology. Two blood cultures were obtained before antibiotic treatment and were incubated at 37°C on 5% sheep blood agar. In addition, stool samples submitted for culture were streaked onto eosin methylene blue, Hektoen enteric agar, and xylose-lysine-deoxycholate plates, and samples of joint fluid submitted for culture were streaked on ThayerMartin and 5% sheep blood agar plates. Ail were incubated at 37°C. After 24 h. all of the cultures yielded pure growth of a gram-negative fermentative bacterium. Biochemical testing was performed with the API 20E system (Analytab shigelloides is found worldwide in surface water but is rarely associated with appearance in the feces of healthy human hosts (16) . Both enteric and extraintestinal infections with P. .shigelloides have been described previously. Cases of enteric infection may occur sporadically or in clusters; however, raw shellfish ingestion or foreign travel or both provide an epidemiologic link with both types of infection (14, 17, 23) . Extraintestinal infections have occurred in immunocompromised patients and include endophthalmitis (5), cellulitis and wound infections (19, 28) , cholecystitis (4), pyometra (28) , and bloodstream infections (1, 6, 7, 9-12, 15, 20, 21) . The patient in this report was similar to the previously reported patients who had P. shigelloides enteritis but, uniquely, represents bloodstream infection in the absence of a demonstrable host immune defect.
Enteric infection caused by P. lshigelloides has been reviewed previously (14) . Commonly, gastrointestinal symptoms and fever occur within 48 h of ingestion of a seafood meal and last an average of 11 days. Several patients have been treated solely with rehydration; however, antibiotic therapy has been associated with a shortened duration of symptoms. In vitro studies to determine the mechanism by which P. shigelloides produces human disease include a negative Sereny test (for enteroinvasive capability) and equivocal findings for the production of enterotoxin (14, 16, 25, 26) .
Reports of extraintestinal infection caused by P. shigelloides have been sporadic. Of five patients whose illness was not associated with bloodstream infection, four patients demonstrated polymicrobial infection and two patients were exposed to contaminated water; no deaths were reported. One patient was thought to be immunocompromised because of preexisting hepatobiliary disease.
Bloodstream infection caused by P. shigelloides is uncommon (Table 1) . No case clustering has been reported, and all of the prior cases were reported in patients demonstrating immune defects. A probable source of infection was found in three cases. A symptomatic diarrhea positive for P. shigelloides was observed in our patient, a positive postmortem stool for P. shigelloides was found in a patient with rheumatoid arthritis, and a positive maternal cervical culture was found for a paracolon species observed in a neonate with meningitis. A fatal outcome was reported in all cases of bloodstream infection, with the exception of our patient and a child with sickle cell anemia who was in crisis. Overall, most of the extraintestinal infections with P. shigelloides, like the extraintestinal infections with the closely related Aerornonas spp., involved patients with solid malignancies, leukemias or lymphomas, collagen-vascular tissue diseases, or hepatobiliary disease (8) .
Prior experience in treating extraintestinal infections caused by P. shigelloides has been limited to isolated case reports. P. shigelloidles has been shown to produce a betalactamase which mediates resistance to most penicillins (22) . In vitro testing of isolates associated with human disease indicates susceptibility to the cephalosporin antibiotics, aminoglycosides, trimethroprim, sulfamethoxazole, tetracycline, chloramphenicol, and the quinolone carboxylic acids, including ciprofloxacin, enoxacin, and norfloxacin, and indicates resistance to erythromycin (3, 22) . Including our patient, 9 of 10 patients with bloodstream infections were treated with antibiotics to which the organism was susceptible. However, the favorable outcome in our patient was more likely related to his previous good health, whereas the NOTES 1793 fatal outcome in other patients may be attributed to the severity of their underlying diseases despite administration of the appropriate antibiotics.
The patient described in this report became ill after ingesting a seafood meal. His blood, stool, and joint fluid cultures were al positive for P. shigelloides. Treatment with several cephalosporin antibiotics to which the organism was susceptible eventually resulted in a cure for his bloodstream infection and osteomyelitis. P. shigelloides should be considered in the differential diagnosis of human diarrheal illness after seafood ingestion. This report adds further evidence that an enteroinvasive form of disease caused by this organism may exist and that the organism may be a rare cause of septicemia associated with a gastrointestinal illness in an immunocompetent host.
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